SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-3
Document Type: S-3
Date Filed: 2025-11-26
Accession Number: 0001213900-25-115554
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025115554/ea0266812-s3_synergy.htm

Chunk 13 of 26
Word Count: 1490
Character Count: 9131

Document Content:

action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in the right of the corporation, by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with the action, suit or proceeding if he: (a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful.

NRS Section 78.7502(2) provides
that a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed
action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that he is or was a director,
officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee
or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement
and attorneys’ fees actually and reasonably incurred by him in connection with the defense or settlement of the action or suit if
he: (a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and in a manner which he reasonably believed to be
in or not opposed to the best interests of the corporation. Indemnification may not be made for any claim, issue or matter as to which
such a person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals there from, to be liable to the
corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or
suit was brought or other court of competent jurisdiction determines upon application that in view of all the circumstances of the case,
the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.

NRS Section 78.747 provides
that except as otherwise provided by specific statute, no director or officer of a corporation is individually liable for a debt or liability
of the corporation, unless the director or officer acts as the alter ego of the corporation. The court as a matter of law must determine
the question of whether a director or officer acts as the alter ego of a corporation.

Our amended and restated bylaws
provide that we will indemnify our directors, officers, employees and agents to the extent and in the manner permitted by the provisions
of the NRS, as amended from time to time, subject to any permissible expansion or limitation of such indemnification, as may be set forth
in any stockholders’ or directors’ resolution or by contract. Any repeal or modification of these provisions approved by our
stockholders will be prospective only and will not adversely affect any limitation on the liability of any of our directors or officers
existing as of the time of such repeal or modification. We are also permitted to apply for insurance on behalf of any director, officer,
employee or other agent for liability arising out of his actions, whether or not the NRS would permit indemnification.

We have entered into agreements
with our officers and directors that provide contractual indemnification in addition to the indemnification provided for in our articles
of incorporation and amended and restated bylaws.

We do not currently carry directors’
and officers’ insurance. However, we may in the future purchase a policy of directors’ and officers’ liability insurance
that insures our officers and directors against the cost of defense, settlement or payment of a judgment in some circumstances and insures
us against our obligations to indemnify our officers and directors.

These provisions may discourage
stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions also may have the effect
of reducing the likelihood of derivative litigation against officers and directors, even though such an action, if successful, might otherwise
benefit us and our stockholders. Furthermore, a stockholder’s investment may be adversely affected to the extent we pay the costs
of settlement and damage awards against officers and directors pursuant to these indemnification provisions.

We believe that these provisions
and the indemnity agreements are necessary to attract and retain talented and experienced officers and directors.

ADDITIONAL INFORMATION

This prospectus is part of
a Registration Statement on Form S-3 that we have filed with the SEC relating to the shares of our securities being offered hereby. This
prospectus does not contain all of the information in the Registration Statement and its exhibits. The Registration Statement, its exhibits
and the documents incorporated by reference in this prospectus and their exhibits, all contain information that is material to the offering
of the securities hereby. Whenever a reference is made in this prospectus to any of our contracts or other documents, the reference may
not be complete. You should refer to the exhibits that are a part of the Registration Statement in order to review a copy of the contract
or documents. The Registration Statement and the exhibits are available at the SEC’s website.

We file annual, quarterly
and current reports, proxy statements and other information with the SEC. The SEC maintains an Internet site at http://www.sec.gov
that contains reports, proxy and information statements, and other information regarding issuers, such as us, that file electronically
with the SEC. Additionally, you may access our filings with the SEC through our website at www.synergychc.com. We have included
our website address as an inactive textual reference only and our website and the information contained on, or that can be accessed through,
our website will not be deemed to be incorporated by reference in, and are not considered part of, this prospectus.

We will provide you without
charge, upon your oral or written request, with an electronic or paper copy of any or all reports, proxy statements and other documents
we file with the SEC, as well as any or all of the documents incorporated by reference in this prospectus (other than exhibits to such
documents unless such exhibits are specifically incorporated by reference into such documents). Requests for such copies should be directed

Synergy CHC Corp.

865 Spring Street

Westbrook, Maine 04092

You should rely only on the
information in this prospectus and the additional information described above and under the heading “Incorporation of Certain Information
by Reference” below. We have not authorized any other person to provide you with different information. If anyone provides you with
different or inconsistent information, you should not rely upon it. We are not making an offer to sell these securities in any jurisdiction
where such offer or sale is not permitted. You should assume that the information in this prospectus was accurate on the date of the front
cover of this prospectus only. Our business, financial condition, results of operations and prospects may have changed since that date.

INCORPORATION OF CERTAIN INFORMATION BY REFERENCE

The SEC allows us to “incorporate
by reference” information that we file with it into this prospectus, which means that we can disclose important information to you
by referring you to those documents. The information incorporated by reference is an important part of this prospectus. The information
incorporated by reference is considered to be a part of this prospectus, and information that we file later with the SEC will automatically
update and supersede information contained in this prospectus and any accompanying prospectus supplement.

We incorporate by reference
the documents listed below that we have previously filed with the SEC:

●	Annual Report on  Form 10-K  for
the year ended December 31, 2024 filed on March 31, 2025;

●	Those portions of our Definitive Proxy Statement on Schedule 14A
for our 2025 Annual Meeting of Stockholders filed with the SEC on April 28, 2025 that are incorporated by reference into our Annual
Report on Form 10-K for the year ended December 31, 2024;

●	Quarterly Reports on Form 10-Q
for the fiscal quarters ended March 31,
2025 , June 30, 2025 and September 30, 2025, respectively, filed on May 15, 2025 , August 14,
2025 , and November 13, 2025 , respectively;

●	Current Report on Form 8-K (excluding
any reports or portions thereof that are deemed to be furnished and not filed) filed on  March 31,
2025 , June 4,
2025 , June 12,
2025 , June 18,
2025 , August 27, 2025 and September 22, 2025 ; and